Financial News

Financial Report: Charles River Labs

Manufacturing Support segment drives growth in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Charles River Labs   4Q Revenues: $353.9 million (+7%) 4Q Earnings: $32.4 million (+17%) FY Revenues: $1.4 billion (+5%) FY Earnings: $151.1 million (+18%) Comments: Revenue for the Research Models and Services segment was $114.7 million in the quarter, down 3%. Discovery and Safety Assessment revenues were $160.5 million, up 7%. Manufacturing Support revenues were $78.6 million, up 26%, reflecting the acquisitions of Celsis and Sunrise Farms, which contributed 14% to revenue growt...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters